ANVS
ANVS
NYSE · Biotechnology

Annovis Bio

$1.80
+0.06 (+3.45%)
As of Aug 18, 10:20 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +703.3% upside
Low Target $8.98
Average Target $14.46
High Target $17.59
Current Price $1.80
Current
$1.80
Target
$14.46
$8.98 $14.46 avg $17.59
Scenario Analysis
Bear Case
$8.98
398.9%
Low target
Base Case
$14.46
+703.3%
Avg target
Bull Case
$17.59
+877.2%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$5.50
-67.3% from high
52-Week Low
$1.54
+16.8% from low
Target vs 52W High
$14.46
+162.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -0.5%
AMGN
Amgen Inc
Hold 43 49% $190.87 -55.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +152.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -17.0%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -54.1%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -47.2%
BIIB
Biogen Inc
Buy 43 67% $91.45 -57.0%